ACHE and Alzheimer disease: In the context of AD, MYR has demonstrated promising effects: it improves learning and memory in streptozotocin-induced rat models, suppresses D-galactose-induced cognitive impairment in mice, inhibits acetylcholinesterase in scopolamine-induced memory impairment, and prevents cognitive decline in similar models [336,337,338].